Boston Scientific’s stock climbs on Q3 sales and earnings beat

Shares of Boston Scientific Corp. rose 1.1% in premarket trades Wednesday after the medical products company reported better-than-expected profit and sales in its third-quarter results, and gave ... Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the consensus estimate of $4.04 billion. Sales increased 19.4% on a reported basis ... Read More

Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High - MSN

Analysts projected $2.41 earnings per share and $16.3 billion in sales. In premarket trades on today's stock market, Boston Scientific stock rose 1.1%, signaling a possible record high at the open. Read More

Boston Scientific stock jumps into record territory after earnings beat ...

Excluding nonrecurring items, adjusted earnings per share rose to 47 cents from 39 cents to beat the FactSet consensus of 43 cents. Sales grew 12.0% to $3.39 billion, above the FactSet consensus ... Read More

Boston Scientific Q3 Earnings Preview - Forbes

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates. Read More

Will Boston Scientific (BSX) Beat Q3 Earnings Estimates?

Boston Scientific Corporation BSX is scheduled to report third-quarter 2022 results on Oct 26, before the opening bell. In the last reported quarter, the company’s earnings per share of 44 cents ... Read More

Boston Scientific stock jumps after Q4 earnings beat estimates

The company generated adjusted earnings per share of $0.55 on net sales of $3.725B (+14.9% Y/Y), both topping analysts estimates. Income exceeded company's own guidance range of $0.49 to $0.52 per ... Read More

Boston Scientific’s stock climbs on Q3 sales and earnings beat - MSN

Related: Boston Scientific’s stock jumps 3% after earnings beat and upbeat guidance The company expects net sales growth for the full year 2024 to be approximately 16.5% on a reported basis and ... Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual ...

Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated. Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual ...

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices. Vandana Singh . Wed, 23 Oct 2024, 10:16 am 2 min read. In this article: BSX . Boston ... Read More